Hypertrophic Cardiomyopathy Association Annual Patient Meeting Empowers Patients & Supporters to Connect, Learn & Thrive
Bighearted patients & families, HCM experts unite for connection, wellness, and empowered care, celebrating 30 years of
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
Bighearted patients & families, HCM experts unite for connection, wellness, and empowered care, celebrating 30 years of the HCMA
DENVILLE, NJ, UNITED STATES, September 9, 2026 /EINPresswire.com/ — The Hypertrophic Cardiomyopathy Association (HCMA) is bringing the leading clinical voices from across the hypertrophic cardiomyopathy (HCM) ecosystem to connect with patients, families, and supporters at the HCMA Annual Patient Meeting on October 10, 2026, at the Hyatt Regency, 3 Speedwell Ave, Morristown, NJ 07960. Hypertrophic Cardiomyopathy (HCM) is a genetic heart muscle disease impacting 1 in 250 worldwide and is the leading cause of sudden cardiac death in the young and a significant cause of heart failure. Today, new diagnostics and therapies are aiding in diagnosis and improving the quality of life of patients and families.
“Living with HCM or other thick hearted muscle disorders can feel overwhelming – but patients and families don’t have to navigate their journeys alone,” Lisa Salberg, Founder & CEO HCMA. The HCMA Annual Patient Meeting provides unique opportunities:
Learn from the experts who provide direct access to the latest updates in HCM research, emerging treatments, and medical advancements.
Find and engage with the community by connecting with fellow patients and families; sharing their stories, exchanging experiences, and engaging with a support network that lasts long after the weekend is over.
Take control of their care by equipping themselves with the education and advocacy tools to make confident, informed decisions about their heart health.
Weekend Schedule & Expert Speakers
Friday, October 9, 2026, 9 AM
The inaugural event of the HCMA’s Hearts & Minds Initiative. A Continuing Education program for mental health professionals that provides a foundation in cardiac psychology with insights into caring for conditions like HCM. The program provides actionable clinical strategies to support patient quality of life and psychological recovery. Facilitated by Samuel F. Sears, PhD, Professor of cardiac psychology at East Carolina University, and Lisa Salberg, Founder & CEO HCMA.
Saturday, October 10, 8:30 AM
Patient-focused and expert-led meeting highlighting topics such as pediatric HCM, family screening, the future of cardiac surgery, evolving therapies, mental health for HCM, the generic drug crisis, and many more, presented by experts like Dr. Martin Maron from Beth Israel Lahey Health, Dr. Milind Desai from Cleveland Clinic, Dr. Rachel Lambert from Yale School of Medicine, Dr. Daniele Massera from NYU Langone Health, Dr. Jeffrey Bennett from Cleveland Clinic Children’s, Adaya Wesissler-Snir, Morristown Medical Center
Click here to register
Saturday, October 10, 6:30 PM
Relax, mingle, and celebrate 30 years of the HCMA with the bighearted community!
Celebrate with the bighearted
Sunday, October 11, 2026, 9 AM
Run, walk, or just have fun at the Bighearted 5K. Walk or run in person or virtually, timed or untimed, to support our bighearted community. Featuring a bounce house for the littles, food trucks, and an HCM memory walk at the HCMA headquarters 66 Ford Road, Denville, NJ 07834.
Click here to run for the bighearted
For media inquiries or interview requests, contact Claudine D’Angelo-Dotzman, Communications Manager, HCMA claudine@4hcm.org or (973) 983-7429 ext. 415.
About the Hypertrophic Cardiomyopathy Association (HCMA)
The HCMA was founded in 1996 to support, advocate for, and educate patients, families, the medical community, and the public about hypertrophic cardiomyopathy and all thick heart muscle disorders, while supporting research and the development of treatments and diagnostics. In it’s 30 year history, the HCMA has served more than 100,000 patients and families with a global membership across more than 100 countries, certified more than 65 Recognized Centers of Excellence across the United States, championed legislation at both the state and federal levels, and brought the voice of patients to the pharmaceutical industry and FDA to encourage the creation of new treatments for HCM and other Bighearted diseases.
The HCMA is a 501(c)(3) headquartered in Denville, NJ.
Claudine D’Angelo-Dotzman
Hypertrophic Cardiomyopathy Association
+1 973-983-7429
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
